Parkinson\u2019s Stages: The Hoehn and Yahr Scale Explained<\/h1><\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/parkinsonsjournal.com\/wp-content\/uploads\/2026\/06\/parkinson-stadien-hoehn-yahr.jpg\" "\\"Stages")
<\/span><\/div><\/div><\/div><\/div><\/div>Parkinson\u2019s disease can look very different from one person to another. Symptoms, progression, and daily limitations vary widely. To describe the broad stage and severity of Parkinson\u2019s motor symptoms, clinicians often use the Hoehn and Yahr scale. The original scale divided Parkinson\u2019s into five broad stages. A modified version later added intermediate stages to describe progression more precisely.<\/p>\n<\/div>
The Hoehn and Yahr scale is simple and widely used. It can help clinicians describe the severity of motor symptoms, especially movement problems, balance, and increasing disability. However, it also has important limitations. It does not capture the many non-motor symptoms of Parkinson\u2019s, such as constipation, sleep problems, mood changes, cognitive changes, pain, dizziness, or bladder problems.<\/p>\n
This article explains what the Hoehn and Yahr scale is, how the different Parkinson\u2019s stages are defined, where the scale is useful, where it falls short, and how the MDS-UPDRS offers a more detailed way to assess Parkinson\u2019s symptoms and daily function.<\/p>\n<\/div>
Contents at a glance<\/div><\/div>- What is the Hoehn and Yahr scale in Parkinson\u2019s disease?<\/a><\/li>
- The stages of Parkinson\u2019s on the Hoehn and Yahr scale<\/a>
- Stage 0: No signs of Parkinson\u2019s<\/a><\/li>
- Stage 1: Mild symptoms on one side of the body<\/a><\/li>
- Stage 1.5: One-sided symptoms with axial involvement<\/a><\/li>
- Stage 2: Symptoms on both sides, balance still intact<\/a><\/li>
- Stage 2.5: Mild balance impairment, recovery on the pull test<\/a><\/li>
- Stage 3: Balance problems and increased fall risk<\/a><\/li>
- Stage 4: Severe symptoms and limited independence<\/a><\/li>
- Stage 5: Wheelchair dependence or bedridden without help<\/a><\/li><\/ul><\/li>
- Limitations of the Hoehn and Yahr scale<\/a>
- It does not measure non-motor symptoms<\/a><\/li>
- It can miss early non-motor warning signs<\/a><\/li>
- It does not capture the full individual experience of Parkinson\u2019s<\/a><\/li>
- Why is the Hoehn and Yahr scale still used?<\/a><\/li><\/ul><\/li>
- What is the MDS-UPDRS?<\/a><\/li>
- Why the MDS-UPDRS is more detailed than the Hoehn and Yahr scale<\/a><\/li>
- MDS-UPDRS: The main areas assessed<\/a>
- Part I: Non-motor experiences of daily living<\/a><\/li>
- Part II: Motor experiences of daily living<\/a><\/li>
- Part III: Motor examination<\/a><\/li>
- Part IV: Motor complications<\/a><\/li><\/ul><\/li>
- Hoehn and Yahr vs. MDS-UPDRS: What is the difference?<\/a><\/li>
- Key takeaways: What do Parkinson\u2019s stages really tell you?<\/a><\/li><\/ul><\/div><\/div><\/div><\/div><\/div>
What is the Hoehn and Yahr scale in Parkinson\u2019s disease?<\/h2>\n
The Hoehn and Yahr scale is used to describe the broad stage and severity of Parkinson\u2019s based mainly on motor impairment, balance, and functional disability. It was introduced in 1967 by neurologists Dr. Margaret Hoehn and Dr. Melvin Yahr. Both were associated with Columbia University in the United States, where they developed a practical staging system to describe how Parkinson\u2019s motor symptoms tend to progress over time.<\/p>\n
The scale focuses mainly on motor symptoms \u2014 especially whether symptoms affect one side or both sides of the body, whether balance is impaired, and how much help a person needs in daily life. In this context, motor symptoms include movement-related problems such as tremor, rigidity, slowness of movement, changes in posture, gait problems, and postural instability.<\/p>\n
Non-motor symptoms are not included in the Hoehn and Yahr staging itself. These can include constipation, sleep disorders, dizziness, urinary symptoms, depression, anxiety, cognitive changes, hallucinations, or Parkinson\u2019s disease dementia. This is one of the main reasons the scale is helpful but incomplete.<\/p>\n
Today, the Hoehn and Yahr scale is still commonly used to describe Parkinson\u2019s disease stage, especially in clinical communication and research. However, it should not be understood as a complete diagnostic tool or as a full picture of how Parkinson\u2019s affects a person\u2019s life.<\/p>\n
The stages of Parkinson\u2019s on the Hoehn and Yahr scale<\/h2>\n
The Hoehn and Yahr scale makes Parkinson\u2019s motor severity easier to describe. The original version had five stages. The modified version includes additional intermediate stages, including stage 1.5 and stage 2.5. These intermediate stages can help describe early progression and mild balance changes more precisely.<\/p>\n
Stages 1 and 2 are generally considered early Parkinson\u2019s. Stage 3 is often described as mid-stage Parkinson\u2019s, because balance problems become more noticeable. Stages 4 and 5 describe more advanced Parkinson\u2019s with major limitations in mobility and independence.<\/p>\n
Stage 0: No signs of Parkinson\u2019s<\/h3>\n
There are no visible signs of Parkinson\u2019s disease.<\/p>\n
Stage 1: Mild symptoms on one side of the body<\/h3>\n
Symptoms are mild and affect only one side of the body. A person may have a slight tremor, mild rigidity, subtle changes in posture, or mild slowness of movement. Daily activities are usually not affected or are only slightly affected.<\/p>\n
Stage 1.5: One-sided symptoms with axial involvement<\/h3>\n
Symptoms are still mainly one-sided, but they also involve the neck, spine, or trunk. This is sometimes called axial involvement. It suggests that the disease has progressed beyond a strictly one-sided presentation, but balance is still generally preserved.<\/p>\n
Stage 2: Symptoms on both sides, balance still intact<\/h3>\n
Symptoms now affect both sides of the body. Movement may be slower, stiffness may be more noticeable, and posture or walking may change. Balance is still preserved. Daily activities may still be manageable, but they may take more effort.<\/p>\n
Stage 2.5: Mild balance impairment, recovery on the pull test<\/h3>\n
Symptoms affect both sides of the body, and there may be mild postural instability. During a pull test, the examiner gently pulls the person backward or forward at the shoulders to assess balance and postural reflexes. In stage 2.5, the person may show some imbalance but is still able to recover.<\/p>\n
Stage 3: Balance problems and increased fall risk<\/h3>\n
In stage 3, symptoms are mild to moderate on both sides of the body, and balance problems become more obvious. A person may have difficulty standing, walking, turning, or recovering from a loss of balance. The risk of falls increases.<\/p>\n
Many people in stage 3 are still physically independent and can walk without assistance. However, daily activities are more clearly affected. Tasks such as dressing, cooking, shopping, or moving through crowded places may become more difficult.<\/p>\n
Stage 4: Severe symptoms and limited independence<\/h3>\n
Stage 4 marks advanced Parkinson\u2019s disease. Movement limitations are severe. A person may still be able to stand or walk, but doing so can be very difficult and may require a walker or other assistive device.<\/p>\n
At this stage, many people need help with daily activities. Independence becomes increasingly limited, and safety, fall prevention, home adaptation, and caregiver support become especially important.<\/p>\n
Stage 5: Wheelchair dependence or bedridden without help<\/h3>\n
Stage 5 is the most advanced stage on the Hoehn and Yahr scale. A person is typically unable to stand or walk without help and may be wheelchair-dependent or bedridden.<\/p>\n
At this stage, the person usually needs substantial assistance with daily activities such as getting dressed, washing, eating, transferring, and moving safely. Advanced Parkinson\u2019s may also involve complications such as swallowing problems, cognitive impairment, hallucinations, or dementia, although these non-motor features are not directly measured by the Hoehn and Yahr scale.<\/p>\n
Limitations of the Hoehn and Yahr scale<\/h2>\n
The Hoehn and Yahr scale is simple and useful, but it is also limited. Its main strength is that it provides a quick overview of motor severity. Its main weakness is that Parkinson\u2019s is far more complex than motor staging alone.<\/p>\n
It does not measure non-motor symptoms<\/h3>\n
The biggest limitation is that the Hoehn and Yahr scale focuses on motor symptoms such as tremor, rigidity, walking problems, and balance impairment. It does not measure the many non-motor symptoms that are common in Parkinson\u2019s.<\/p>\n
These non-motor symptoms can include:<\/p>\n
\n- Constipation<\/li>\n
- Sleep problems<\/li>\n
- REM sleep behavior disorder<\/li>\n
- Depression<\/li>\n
- Anxiety<\/li>\n
- Cognitive changes<\/li>\n
- Hallucinations<\/li>\n
- Pain<\/li>\n
- Fatigue<\/li>\n
- Dizziness or blood pressure changes<\/li>\n
- Urinary problems<\/li>\n
- Sexual dysfunction<\/li>\n
- Swallowing problems<\/li>\n
- Parkinson\u2019s disease dementia<\/li>\n<\/ul>\n
For many people, these non-motor symptoms can be just as burdensome as movement symptoms \u2014 sometimes even more so. A person may have relatively mild motor symptoms but still experience major impairment from sleep problems, depression, pain, fatigue, or cognitive changes. The Hoehn and Yahr scale does not capture that.<\/p>\n
It can miss early non-motor warning signs<\/h3>\n
Because the Hoehn and Yahr scale focuses on motor symptoms, it does not reflect early non-motor signs that may appear years before a Parkinson\u2019s diagnosis. These can include a reduced sense of smell, constipation, REM sleep behavior disorder, depression, or subtle autonomic symptoms.<\/p>\n
These early warning signs do not prove that someone has Parkinson\u2019s, but they can be clinically important when they occur together or in the right context. A staging scale based mainly on movement cannot fully capture this early phase of the disease.<\/p>\n
It does not capture the full individual experience of Parkinson\u2019s<\/h3>\n
Parkinson\u2019s affects each person differently. Two people in the same Hoehn and Yahr stage may have very different symptoms, treatment needs, levels of independence, emotional burden, and quality of life.<\/p>\n
For example, one person in stage 2 may be mainly troubled by tremor, while another may struggle more with stiffness, fatigue, sleep disruption, or anxiety. One person in stage 3 may still manage daily life well with exercise and therapy, while another may experience frequent falls, freezing of gait, or major fear of falling.<\/p>\n
The Hoehn and Yahr scale gives a broad motor stage. It does not describe all symptom types, treatment complications, cognitive and emotional changes, care needs, or the person\u2019s lived experience.<\/p>\n<\/div>
Why is the Hoehn and Yahr scale still used?<\/h3><\/div>The Hoehn and Yahr scale is still used because it is simple, quick, and widely understood. It gives clinicians, researchers, and patients a common language for describing broad stages of motor progression in Parkinson\u2019s.<\/p>\n
However, it should be used as one part of a broader assessment \u2014 not as the only way to evaluate Parkinson\u2019s disease. More detailed tools, such as the MDS-UPDRS, can provide a fuller picture of motor symptoms, non-motor symptoms, daily function, and treatment complications.<\/p>\n<\/div><\/div><\/div><\/div>
What is the MDS-UPDRS?<\/h2>\n
The MDS-UPDRS stands for Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale. It is a detailed clinical rating scale used to assess Parkinson\u2019s disease more comprehensively than the Hoehn and Yahr scale alone.<\/p>\n
The original UPDRS was developed to measure different aspects of Parkinson\u2019s disease. The Movement Disorder Society later revised it into the MDS-UPDRS to better capture the wide range of Parkinson\u2019s symptoms and their impact on daily life.<\/p>\n
While the Hoehn and Yahr scale gives a broad motor stage, the MDS-UPDRS evaluates multiple dimensions of Parkinson\u2019s, including non-motor experiences, motor experiences of daily living, the motor examination, and motor complications from treatment.<\/p>\n
Why the MDS-UPDRS is more detailed than the Hoehn and Yahr scale<\/h2>\n
The MDS-UPDRS is more detailed because it does not focus only on broad motor stage. It looks at how Parkinson\u2019s affects daily life, movement, treatment response, and complications.<\/p>\n
It can help clinicians assess:<\/p>\n
\n- How symptoms affect everyday activities<\/li>\n
- How motor symptoms appear during examination<\/li>\n
- How non-motor symptoms affect daily life<\/li>\n
- Whether treatment causes complications such as dyskinesias or motor fluctuations<\/li>\n
- How symptoms change over time<\/li>\n
- Which areas may need medication changes, therapy, or additional support<\/li>\n<\/ul>\n
For this reason, the MDS-UPDRS is widely used in specialist care and clinical research. It does not replace clinical judgment, but it provides a structured way to document Parkinson\u2019s severity and progression more precisely.<\/p>\n
MDS-UPDRS: The main areas assessed<\/h2>\n
The MDS-UPDRS is divided into several parts. Together, these parts provide a broader picture of Parkinson\u2019s disease than the Hoehn and Yahr scale alone.<\/p>\n
Part I: Non-motor experiences of daily living<\/h3>\n
This part assesses non-motor symptoms and how they affect daily life. These may include:<\/p>\n
\n- Cognitive changes<\/li>\n
- Hallucinations or psychosis<\/li>\n
- Depressed mood<\/li>\n
- Anxiety<\/li>\n
- Apathy or reduced motivation<\/li>\n
- Sleep problems<\/li>\n
- Daytime sleepiness<\/li>\n
- Pain or other sensory symptoms<\/li>\n
- Urinary problems<\/li>\n
- Constipation<\/li>\n
- Lightheadedness when standing<\/li>\n
- Fatigue<\/li>\n<\/ul>\n
Part II: Motor experiences of daily living<\/h3>\n
This part looks at how motor symptoms affect everyday activities. These may include:<\/p>\n
\n- Speech<\/li>\n
- Saliva and drooling<\/li>\n
- Chewing and swallowing<\/li>\n
- Eating tasks<\/li>\n
- Dressing<\/li>\n
- Hygiene<\/li>\n
- Handwriting, including micrographia<\/li>\n
- Hobbies and other activities<\/li>\n
- Turning in bed<\/li>\n
- Tremor<\/li>\n
- Getting out of bed, a car, or a deep chair<\/li>\n
- Walking and balance<\/li>\n
- Freezing of gait<\/li>\n<\/ul>\n
Part III: Motor examination<\/h3>\n
This part is completed through a clinical motor exam. It assesses movement signs such as:<\/p>\n
\n- Speech<\/li>\n
- Facial expression, including reduced facial expression<\/li>\n
- Rigidity<\/li>\n
- Finger tapping<\/li>\n
- Hand movements<\/li>\n
- Pronation-supination movements of the hands<\/li>\n
- Toe tapping<\/li>\n
- Leg agility<\/li>\n
- Rising from a chair<\/li>\n
- Gait<\/li>\n
- Freezing of gait<\/li>\n
- Postural stability<\/li>\n
- Posture<\/li>\n
- Global spontaneity of movement<\/li>\n
- Postural tremor of the hands<\/li>\n
- Kinetic tremor of the hands<\/li>\n
- Rest tremor<\/li>\n
- Bradykinesia<\/li>\n<\/ul>\n
Part IV: Motor complications<\/h3>\n
This part assesses complications related to Parkinson\u2019s treatment, especially in more advanced disease. These may include:<\/p>\n
\n- Dyskinesias<\/li>\n
- How much time dyskinesias are present<\/li>\n
- Whether dyskinesias interfere with daily function<\/li>\n
- Motor fluctuations<\/li>\n
- Off time<\/li>\n
- Functional impact of fluctuations<\/li>\n
- Painful off-state dystonia<\/li>\n<\/ul>\n
Hoehn and Yahr vs. MDS-UPDRS: What is the difference?<\/h2>\n
The Hoehn and Yahr scale and the MDS-UPDRS are both used in Parkinson\u2019s care and research, but they answer different questions.<\/p>\n
The Hoehn and Yahr scale gives a broad stage of Parkinson\u2019s based mainly on motor symptoms, balance, and disability.<\/p>\n
The MDS-UPDRS gives a more detailed assessment of how Parkinson\u2019s affects symptoms, daily life, motor function, non-motor symptoms, and treatment complications.<\/p>\n
In simple terms:<\/p>\n
\n- The Hoehn and Yahr scale answers: \u201cWhat broad motor stage is this person in?\u201d<\/li>\n
- The MDS-UPDRS answers: \u201cHow is Parkinson\u2019s affecting this person across multiple areas of life and treatment?\u201d<\/li>\n<\/ul>\n
Both can be useful. But neither scale replaces an individualized clinical assessment. Parkinson\u2019s care should always consider the person\u2019s symptoms, goals, medications, side effects, independence, cognition, mood, support system, and quality of life.<\/p>\n
Key takeaways: What do Parkinson\u2019s stages really tell you?<\/h2>\n
Parkinson\u2019s stages can help describe the broad progression of motor symptoms, but they do not tell the whole story. The Hoehn and Yahr scale is useful because it is simple and widely recognized. It shows whether symptoms are one-sided or bilateral, whether balance is affected, and how much mobility and independence have changed.<\/p>\n
However, Parkinson\u2019s is more than movement. Non-motor symptoms, emotional health, sleep, cognition, pain, fatigue, treatment effects, and quality of life are not captured well by Hoehn and Yahr staging.<\/p>\n
That is why a person\u2019s Parkinson\u2019s stage should never be interpreted in isolation. A stage can provide orientation, but it cannot describe the full experience of living with Parkinson\u2019s. The most useful assessment combines staging with detailed symptom review, clinical examination, therapy response, daily function, and the person\u2019s own priorities.<\/p>\n<\/div><\/div><\/div>
Also worth reading<\/div><\/div>
<\/span><\/div><\/div><\/div><\/div><\/div>Parkinson\u2019s disease can look very different from one person to another. Symptoms, progression, and daily limitations vary widely. To describe the broad stage and severity of Parkinson\u2019s motor symptoms, clinicians often use the Hoehn and Yahr scale. The original scale divided Parkinson\u2019s into five broad stages. A modified version later added intermediate stages to describe progression more precisely.<\/p>\n<\/div>
The Hoehn and Yahr scale is simple and widely used. It can help clinicians describe the severity of motor symptoms, especially movement problems, balance, and increasing disability. However, it also has important limitations. It does not capture the many non-motor symptoms of Parkinson\u2019s, such as constipation, sleep problems, mood changes, cognitive changes, pain, dizziness, or bladder problems.<\/p>\n
This article explains what the Hoehn and Yahr scale is, how the different Parkinson\u2019s stages are defined, where the scale is useful, where it falls short, and how the MDS-UPDRS offers a more detailed way to assess Parkinson\u2019s symptoms and daily function.<\/p>\n<\/div>
- What is the Hoehn and Yahr scale in Parkinson\u2019s disease?<\/a><\/li>
- The stages of Parkinson\u2019s on the Hoehn and Yahr scale<\/a>
- Stage 0: No signs of Parkinson\u2019s<\/a><\/li>
- Stage 1: Mild symptoms on one side of the body<\/a><\/li>
- Stage 1.5: One-sided symptoms with axial involvement<\/a><\/li>
- Stage 2: Symptoms on both sides, balance still intact<\/a><\/li>
- Stage 2.5: Mild balance impairment, recovery on the pull test<\/a><\/li>
- Stage 3: Balance problems and increased fall risk<\/a><\/li>
- Stage 4: Severe symptoms and limited independence<\/a><\/li>
- Stage 5: Wheelchair dependence or bedridden without help<\/a><\/li><\/ul><\/li>
- Limitations of the Hoehn and Yahr scale<\/a>
- It does not measure non-motor symptoms<\/a><\/li>
- It can miss early non-motor warning signs<\/a><\/li>
- It does not capture the full individual experience of Parkinson\u2019s<\/a><\/li>
- Why is the Hoehn and Yahr scale still used?<\/a><\/li><\/ul><\/li>
- What is the MDS-UPDRS?<\/a><\/li>
- Why the MDS-UPDRS is more detailed than the Hoehn and Yahr scale<\/a><\/li>
- MDS-UPDRS: The main areas assessed<\/a>
- Part I: Non-motor experiences of daily living<\/a><\/li>
- Part II: Motor experiences of daily living<\/a><\/li>
- Part III: Motor examination<\/a><\/li>
- Part IV: Motor complications<\/a><\/li><\/ul><\/li>
- Hoehn and Yahr vs. MDS-UPDRS: What is the difference?<\/a><\/li>
- Key takeaways: What do Parkinson\u2019s stages really tell you?<\/a><\/li><\/ul><\/div><\/div><\/div><\/div><\/div>
What is the Hoehn and Yahr scale in Parkinson\u2019s disease?<\/h2>\n
The Hoehn and Yahr scale is used to describe the broad stage and severity of Parkinson\u2019s based mainly on motor impairment, balance, and functional disability. It was introduced in 1967 by neurologists Dr. Margaret Hoehn and Dr. Melvin Yahr. Both were associated with Columbia University in the United States, where they developed a practical staging system to describe how Parkinson\u2019s motor symptoms tend to progress over time.<\/p>\n
The scale focuses mainly on motor symptoms \u2014 especially whether symptoms affect one side or both sides of the body, whether balance is impaired, and how much help a person needs in daily life. In this context, motor symptoms include movement-related problems such as tremor, rigidity, slowness of movement, changes in posture, gait problems, and postural instability.<\/p>\n
Non-motor symptoms are not included in the Hoehn and Yahr staging itself. These can include constipation, sleep disorders, dizziness, urinary symptoms, depression, anxiety, cognitive changes, hallucinations, or Parkinson\u2019s disease dementia. This is one of the main reasons the scale is helpful but incomplete.<\/p>\n
Today, the Hoehn and Yahr scale is still commonly used to describe Parkinson\u2019s disease stage, especially in clinical communication and research. However, it should not be understood as a complete diagnostic tool or as a full picture of how Parkinson\u2019s affects a person\u2019s life.<\/p>\n
The stages of Parkinson\u2019s on the Hoehn and Yahr scale<\/h2>\n
The Hoehn and Yahr scale makes Parkinson\u2019s motor severity easier to describe. The original version had five stages. The modified version includes additional intermediate stages, including stage 1.5 and stage 2.5. These intermediate stages can help describe early progression and mild balance changes more precisely.<\/p>\n
Stages 1 and 2 are generally considered early Parkinson\u2019s. Stage 3 is often described as mid-stage Parkinson\u2019s, because balance problems become more noticeable. Stages 4 and 5 describe more advanced Parkinson\u2019s with major limitations in mobility and independence.<\/p>\n
Stage 0: No signs of Parkinson\u2019s<\/h3>\n
There are no visible signs of Parkinson\u2019s disease.<\/p>\n
Stage 1: Mild symptoms on one side of the body<\/h3>\n
Symptoms are mild and affect only one side of the body. A person may have a slight tremor, mild rigidity, subtle changes in posture, or mild slowness of movement. Daily activities are usually not affected or are only slightly affected.<\/p>\n
Stage 1.5: One-sided symptoms with axial involvement<\/h3>\n
Symptoms are still mainly one-sided, but they also involve the neck, spine, or trunk. This is sometimes called axial involvement. It suggests that the disease has progressed beyond a strictly one-sided presentation, but balance is still generally preserved.<\/p>\n
Stage 2: Symptoms on both sides, balance still intact<\/h3>\n
Symptoms now affect both sides of the body. Movement may be slower, stiffness may be more noticeable, and posture or walking may change. Balance is still preserved. Daily activities may still be manageable, but they may take more effort.<\/p>\n
Stage 2.5: Mild balance impairment, recovery on the pull test<\/h3>\n
Symptoms affect both sides of the body, and there may be mild postural instability. During a pull test, the examiner gently pulls the person backward or forward at the shoulders to assess balance and postural reflexes. In stage 2.5, the person may show some imbalance but is still able to recover.<\/p>\n
Stage 3: Balance problems and increased fall risk<\/h3>\n
In stage 3, symptoms are mild to moderate on both sides of the body, and balance problems become more obvious. A person may have difficulty standing, walking, turning, or recovering from a loss of balance. The risk of falls increases.<\/p>\n
Many people in stage 3 are still physically independent and can walk without assistance. However, daily activities are more clearly affected. Tasks such as dressing, cooking, shopping, or moving through crowded places may become more difficult.<\/p>\n
Stage 4: Severe symptoms and limited independence<\/h3>\n
Stage 4 marks advanced Parkinson\u2019s disease. Movement limitations are severe. A person may still be able to stand or walk, but doing so can be very difficult and may require a walker or other assistive device.<\/p>\n
At this stage, many people need help with daily activities. Independence becomes increasingly limited, and safety, fall prevention, home adaptation, and caregiver support become especially important.<\/p>\n
Stage 5: Wheelchair dependence or bedridden without help<\/h3>\n
Stage 5 is the most advanced stage on the Hoehn and Yahr scale. A person is typically unable to stand or walk without help and may be wheelchair-dependent or bedridden.<\/p>\n
At this stage, the person usually needs substantial assistance with daily activities such as getting dressed, washing, eating, transferring, and moving safely. Advanced Parkinson\u2019s may also involve complications such as swallowing problems, cognitive impairment, hallucinations, or dementia, although these non-motor features are not directly measured by the Hoehn and Yahr scale.<\/p>\n
Limitations of the Hoehn and Yahr scale<\/h2>\n
The Hoehn and Yahr scale is simple and useful, but it is also limited. Its main strength is that it provides a quick overview of motor severity. Its main weakness is that Parkinson\u2019s is far more complex than motor staging alone.<\/p>\n
It does not measure non-motor symptoms<\/h3>\n
The biggest limitation is that the Hoehn and Yahr scale focuses on motor symptoms such as tremor, rigidity, walking problems, and balance impairment. It does not measure the many non-motor symptoms that are common in Parkinson\u2019s.<\/p>\n
These non-motor symptoms can include:<\/p>\n
- \n
- Constipation<\/li>\n
- Sleep problems<\/li>\n
- REM sleep behavior disorder<\/li>\n
- Depression<\/li>\n
- Anxiety<\/li>\n
- Cognitive changes<\/li>\n
- Hallucinations<\/li>\n
- Pain<\/li>\n
- Fatigue<\/li>\n
- Dizziness or blood pressure changes<\/li>\n
- Urinary problems<\/li>\n
- Sexual dysfunction<\/li>\n
- Swallowing problems<\/li>\n
- Parkinson\u2019s disease dementia<\/li>\n<\/ul>\n
For many people, these non-motor symptoms can be just as burdensome as movement symptoms \u2014 sometimes even more so. A person may have relatively mild motor symptoms but still experience major impairment from sleep problems, depression, pain, fatigue, or cognitive changes. The Hoehn and Yahr scale does not capture that.<\/p>\n
It can miss early non-motor warning signs<\/h3>\n
Because the Hoehn and Yahr scale focuses on motor symptoms, it does not reflect early non-motor signs that may appear years before a Parkinson\u2019s diagnosis. These can include a reduced sense of smell, constipation, REM sleep behavior disorder, depression, or subtle autonomic symptoms.<\/p>\n
These early warning signs do not prove that someone has Parkinson\u2019s, but they can be clinically important when they occur together or in the right context. A staging scale based mainly on movement cannot fully capture this early phase of the disease.<\/p>\n
It does not capture the full individual experience of Parkinson\u2019s<\/h3>\n
Parkinson\u2019s affects each person differently. Two people in the same Hoehn and Yahr stage may have very different symptoms, treatment needs, levels of independence, emotional burden, and quality of life.<\/p>\n
For example, one person in stage 2 may be mainly troubled by tremor, while another may struggle more with stiffness, fatigue, sleep disruption, or anxiety. One person in stage 3 may still manage daily life well with exercise and therapy, while another may experience frequent falls, freezing of gait, or major fear of falling.<\/p>\n
The Hoehn and Yahr scale gives a broad motor stage. It does not describe all symptom types, treatment complications, cognitive and emotional changes, care needs, or the person\u2019s lived experience.<\/p>\n<\/div>
Why is the Hoehn and Yahr scale still used?<\/h3><\/div>
The Hoehn and Yahr scale is still used because it is simple, quick, and widely understood. It gives clinicians, researchers, and patients a common language for describing broad stages of motor progression in Parkinson\u2019s.<\/p>\n
However, it should be used as one part of a broader assessment \u2014 not as the only way to evaluate Parkinson\u2019s disease. More detailed tools, such as the MDS-UPDRS, can provide a fuller picture of motor symptoms, non-motor symptoms, daily function, and treatment complications.<\/p>\n<\/div><\/div><\/div><\/div>
What is the MDS-UPDRS?<\/h2>\n
The MDS-UPDRS stands for Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale. It is a detailed clinical rating scale used to assess Parkinson\u2019s disease more comprehensively than the Hoehn and Yahr scale alone.<\/p>\n
The original UPDRS was developed to measure different aspects of Parkinson\u2019s disease. The Movement Disorder Society later revised it into the MDS-UPDRS to better capture the wide range of Parkinson\u2019s symptoms and their impact on daily life.<\/p>\n
While the Hoehn and Yahr scale gives a broad motor stage, the MDS-UPDRS evaluates multiple dimensions of Parkinson\u2019s, including non-motor experiences, motor experiences of daily living, the motor examination, and motor complications from treatment.<\/p>\n
Why the MDS-UPDRS is more detailed than the Hoehn and Yahr scale<\/h2>\n
The MDS-UPDRS is more detailed because it does not focus only on broad motor stage. It looks at how Parkinson\u2019s affects daily life, movement, treatment response, and complications.<\/p>\n
It can help clinicians assess:<\/p>\n
- \n
- How symptoms affect everyday activities<\/li>\n
- How motor symptoms appear during examination<\/li>\n
- How non-motor symptoms affect daily life<\/li>\n
- Whether treatment causes complications such as dyskinesias or motor fluctuations<\/li>\n
- How symptoms change over time<\/li>\n
- Which areas may need medication changes, therapy, or additional support<\/li>\n<\/ul>\n
For this reason, the MDS-UPDRS is widely used in specialist care and clinical research. It does not replace clinical judgment, but it provides a structured way to document Parkinson\u2019s severity and progression more precisely.<\/p>\n
MDS-UPDRS: The main areas assessed<\/h2>\n
The MDS-UPDRS is divided into several parts. Together, these parts provide a broader picture of Parkinson\u2019s disease than the Hoehn and Yahr scale alone.<\/p>\n
Part I: Non-motor experiences of daily living<\/h3>\n
This part assesses non-motor symptoms and how they affect daily life. These may include:<\/p>\n
- \n
- Cognitive changes<\/li>\n
- Hallucinations or psychosis<\/li>\n
- Depressed mood<\/li>\n
- Anxiety<\/li>\n
- Apathy or reduced motivation<\/li>\n
- Sleep problems<\/li>\n
- Daytime sleepiness<\/li>\n
- Pain or other sensory symptoms<\/li>\n
- Urinary problems<\/li>\n
- Constipation<\/li>\n
- Lightheadedness when standing<\/li>\n
- Fatigue<\/li>\n<\/ul>\n
Part II: Motor experiences of daily living<\/h3>\n
This part looks at how motor symptoms affect everyday activities. These may include:<\/p>\n
- \n
- Speech<\/li>\n
- Saliva and drooling<\/li>\n
- Chewing and swallowing<\/li>\n
- Eating tasks<\/li>\n
- Dressing<\/li>\n
- Hygiene<\/li>\n
- Handwriting, including micrographia<\/li>\n
- Hobbies and other activities<\/li>\n
- Turning in bed<\/li>\n
- Tremor<\/li>\n
- Getting out of bed, a car, or a deep chair<\/li>\n
- Walking and balance<\/li>\n
- Freezing of gait<\/li>\n<\/ul>\n
Part III: Motor examination<\/h3>\n
This part is completed through a clinical motor exam. It assesses movement signs such as:<\/p>\n
- \n
- Speech<\/li>\n
- Facial expression, including reduced facial expression<\/li>\n
- Rigidity<\/li>\n
- Finger tapping<\/li>\n
- Hand movements<\/li>\n
- Pronation-supination movements of the hands<\/li>\n
- Toe tapping<\/li>\n
- Leg agility<\/li>\n
- Rising from a chair<\/li>\n
- Gait<\/li>\n
- Freezing of gait<\/li>\n
- Postural stability<\/li>\n
- Posture<\/li>\n
- Global spontaneity of movement<\/li>\n
- Postural tremor of the hands<\/li>\n
- Kinetic tremor of the hands<\/li>\n
- Rest tremor<\/li>\n
- Bradykinesia<\/li>\n<\/ul>\n
Part IV: Motor complications<\/h3>\n
This part assesses complications related to Parkinson\u2019s treatment, especially in more advanced disease. These may include:<\/p>\n
- \n
- Dyskinesias<\/li>\n
- How much time dyskinesias are present<\/li>\n
- Whether dyskinesias interfere with daily function<\/li>\n
- Motor fluctuations<\/li>\n
- Off time<\/li>\n
- Functional impact of fluctuations<\/li>\n
- Painful off-state dystonia<\/li>\n<\/ul>\n
Hoehn and Yahr vs. MDS-UPDRS: What is the difference?<\/h2>\n
The Hoehn and Yahr scale and the MDS-UPDRS are both used in Parkinson\u2019s care and research, but they answer different questions.<\/p>\n
The Hoehn and Yahr scale gives a broad stage of Parkinson\u2019s based mainly on motor symptoms, balance, and disability.<\/p>\n
The MDS-UPDRS gives a more detailed assessment of how Parkinson\u2019s affects symptoms, daily life, motor function, non-motor symptoms, and treatment complications.<\/p>\n
In simple terms:<\/p>\n
- \n
- The Hoehn and Yahr scale answers: \u201cWhat broad motor stage is this person in?\u201d<\/li>\n
- The MDS-UPDRS answers: \u201cHow is Parkinson\u2019s affecting this person across multiple areas of life and treatment?\u201d<\/li>\n<\/ul>\n
Both can be useful. But neither scale replaces an individualized clinical assessment. Parkinson\u2019s care should always consider the person\u2019s symptoms, goals, medications, side effects, independence, cognition, mood, support system, and quality of life.<\/p>\n
Key takeaways: What do Parkinson\u2019s stages really tell you?<\/h2>\n
Parkinson\u2019s stages can help describe the broad progression of motor symptoms, but they do not tell the whole story. The Hoehn and Yahr scale is useful because it is simple and widely recognized. It shows whether symptoms are one-sided or bilateral, whether balance is affected, and how much mobility and independence have changed.<\/p>\n
However, Parkinson\u2019s is more than movement. Non-motor symptoms, emotional health, sleep, cognition, pain, fatigue, treatment effects, and quality of life are not captured well by Hoehn and Yahr staging.<\/p>\n
That is why a person\u2019s Parkinson\u2019s stage should never be interpreted in isolation. A stage can provide orientation, but it cannot describe the full experience of living with Parkinson\u2019s. The most useful assessment combines staging with detailed symptom review, clinical examination, therapy response, daily function, and the person\u2019s own priorities.<\/p>\n<\/div><\/div><\/div>
Also worth reading<\/div><\/div>
- Part II: Motor experiences of daily living<\/a><\/li>
- It can miss early non-motor warning signs<\/a><\/li>
- Stage 1: Mild symptoms on one side of the body<\/a><\/li>
- The stages of Parkinson\u2019s on the Hoehn and Yahr scale<\/a>
![\"\"](\"https:\/\/parkinsonsjournal.com\/wp-content\/uploads\/2026\/06\/dopaminmangel-parkinson.jpg\")
\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>![\"\"](\"https:\/\/parkinsonsjournal.com\/wp-content\/uploads\/2026\/06\/apomorphin-parkinson.jpg\")
\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>